EUVIMEDEUVIMED entdecken
Validierungsstudie

Independent Validation of a HER2-Low Focused Immunohistochemistry Scoring System for Enhanced Pathologist Precision and Consistency

Gelareh Farshid, Jane Armes, Benjamin Dessauvagie, Amardeep Gilhotra, Beena Kumar, Hema Mahajan, Ewan Millar, Nirmala Pathmanathan, Cameron Snell

Modern Pathology · 2025-04 · 38 (4) · 100693

DOI: 10.1016/j.modpat.2024.100693 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Modern Pathology, 2025-04. Verfasst von Gelareh Farshid und 8 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Medicine, Adelaide University, Adelaide, Australia; Directorate of Anatomical Pathology, SA Pathology, Royal Adelaide Hospital, Adelaid…. Hauptthemen laut MEDLINE: Erb-b2 Receptor Tyrosine Kinases, Breast Neoplasms, Immunohistochemistry, Biomarkers, Tumor. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: AstraZeneca Australia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Erb-b2 Receptor Tyrosine KinasesBreast NeoplasmsImmunohistochemistryBiomarkers, TumorHumansFemaleReproducibility of ResultsPathologists

Stichwörter der Autor:innen

HER2breast cancerimmunohistochemistry

Substanzen

Erb-b2 Receptor Tyrosine KinasesBiomarkers, TumorERBB2 protein, human

Autor:innen und Institutionen

  • Discipline of Medicine, Adelaide University, Adelaide, Australia; Directorate of Anatomical Pathology, SA Pathology, Royal Adelaide Hospital, Adelaide, Australia. Electronic address: gelareh.farshid2@sa.gov.au.
  • Sullivan Nicolaides Pathology, Birtinya, Queensland, Australia.
  • Clinipath Pathology, A Division of Sonic Healthcare Australia Pathology, Osborne Park, Australia; Pathology and Laboratory Medicine, Medical School, Perth, Australia.
  • Directorate of Anatomical Pathology, SA Pathology, Royal Adelaide Hospital, Adelaide, Australia.
  • Monash Health Pathology, Anatomical Pathology and Diagnostic Genomics, Monash Health, Melbourne, Victoria, Australia.
  • NSW Health Pathology, Department of Anatomical Pathology, St George Hospital, Kogarah, Australia; School of Clinical Medicine, UNSW Medicine & Health, Sydney, Australia.

Förderung

  • AstraZeneca Australia

Zitieren

APA

Farshid, G., Armes, J., Dessauvagie, B., Gilhotra, A., Kumar, B., Mahajan, H., Millar, E., Pathmanathan, N., & Snell, C. (2025). Independent Validation of a HER2-Low Focused Immunohistochemistry Scoring System for Enhanced Pathologist Precision and Consistency. Modern Pathology, 38(4), 100693. https://doi.org/10.1016/j.modpat.2024.100693

Vancouver

Farshid G, Armes J, Dessauvagie B, Gilhotra A, Kumar B, Mahajan H, et al. Independent Validation of a HER2-Low Focused Immunohistochemistry Scoring System for Enhanced Pathologist Precision and Consistency. Modern Pathology. 2025;38(4):100693. doi:10.1016/j.modpat.2024.100693

BibTeX
@article{Farshid2025,
  author = {Farshid, Gelareh and Armes, Jane and Dessauvagie, Benjamin and Gilhotra, Amardeep and Kumar, Beena and Mahajan, Hema and Millar, Ewan and Pathmanathan, Nirmala and Snell, Cameron},
  title = {Independent Validation of a HER2-Low Focused Immunohistochemistry Scoring System for Enhanced Pathologist Precision and Consistency},
  journal = {Modern Pathology},
  year = {2025},
  volume = {38},
  number = {4},
  pages = {100693},
  doi = {10.1016/j.modpat.2024.100693}
}
Kostenlos starten →